Research Article
Clinical Relationship between Steatocholecystitis and Gallbladder Contractility Measured by Cholescintigraphy
Table 3
Univariable analysis for clinical risk factors of steatocholecystitis in patients with acalculous cholecystitis.
| | Variable | Steatocholecystitis
(, 20.7%) | Nonsteatocholecystitis
(, 79.3%) | value |
| | Age (years, mean ± SD) | 46.8 ± 10.8 | 58 ± 15.2 | <0.001 | | Men/women (%) | 7 (29.2)/17 (70.8) | 49 (53.3)/43 (46.7) | 0.04 | | DM (%) | 1 (4.2) | 10 (10.9) | 0.46 | | HTN (%) | 7 (29.2) | 29 (31.5) | >0.99 | | BMI (kg/m2, mean ± SD) | 26.0 ± 3.8 | 24.2 ± 3.2 | 0.02 | | Hb (g/dL, mean ± SD) | 13.5 ± 1.2 | 13.6 ± 1.8 | 0.76 | | Platelet (103/mm3, mean ± SD) | 284.7 ± 69.1 | 267.6 ± 83.9 | 0.36 | | AST (IU/L, mean ± SD) | 25.6 ± 10.3 | 32.3 ± 19.5 | 0.03 | | ALT (IU/L, mean ± SD) | 31.8 ± 28.6 | 34.7 ± 27.4 | 0.65 | | Total bilirubin (mg/dL, mean ± SD) | 0.7 ± 0.3 | 1.0 ± 0.9 | 0.01 | | Total cholesterol (mg/dL, mean ± SD) | 188.3 ± 37.7 | 164.4 ± 39.6 | 0.01 | TG (mg/dL, mean ± SD)
(median/IQR) | 102.1 ± 65
76/69–120 | 111.4 ± 84.4
91.5/59.5–126.8 | 0.66
0.65 | | LDL (mg/dL, mean ± SD) | 113.1 ± 25.1 | 94.6 ± 30.8 | 0.02 | | HDL (mg/dL, mean ± SD) | 51.7 ± 10 | 50.3 ± 13.2 | 0.67 | | GBEF (%, mean ± SD) | 61 ± 38.1 | 32.5 ± 39.6 | 0.002 |
|
|
SD: standard deviation; : number; DM: diabetes mellitus; HTN: hypertension; GB: gallbladder; BMI: body mass index; Hb: hemoglobin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TG: triglyceride; IQR: interquartile range; LDL: low-density lipoprotein; HDL: high-density lipoprotein; GBEF: gallbladder ejection fraction.
|
